Abstract:Purpose: Bacteria-mediated tumor therapy has showed promising potential for cancer therapy. However, the efficacy of bacterial monotherapy treatment which can express and release therapeutic proteins in tumors has been found to be unsatisfactory. To date, synergistic therapy has emerged as a promising approach to achieve stronger therapeutic outcomes compared to bacterial monotherapy. It is a challenge to visualize these tumor-homing bacteria in vivo and guide them to express and release in situ therapeutic proteins. Procedure: We have developed a kind of engineered bacteria (named CGB@ICG) genetically incorporating acoustic reporter proteins and thermo-inducible ClyA expression gene circuit and chemically modified with indocyanine green on the bacterial surface. The presence of acoustic reporter proteins and indocyanine green facilitates the visualization of CGB@ICG via contrast-enhanced ultrasound imaging and optical imaging, making it possible to guide the sound wave or laser to irradiate precisely these bacteria for inducing the expression of ClyA protein via acoustic- or photothermal effects. The expression and secretion of ClyA protein in the tumor, combined with photothermal therapy, greatly enhanced the anti-tumor efficacy of the engineered bacteria and improved their biosafety. Results: We successfully performed multimodal imaging of CGB@ICG in vivo resulting in remoting control the expression of ClyA protein in tumor. In vivo experiments showed that bacteria-mediated therapy combined photothermal therapy exhibited a rapid decrease in tumor volume compared to other groups, while the tumor volume of the combination therapy group continued to decrease and even achieved complete healing. Thus, combination therapy not only reduced the rate of tumor growth but also prevented the proliferation of tumor cells for an extended period. Conclusion: Our study demonstrated that CGB@ICG serves as an efficacious imaging agent and delivery vector to combine engineered bacteria with photothermal therapy, holding great promise for tumor treatment.

Ultrasound-visible engineered bacteria for tumor chemo-immunotherapy

Spatiotemporal control of engineered bacteria to express interferon-γ by focused ultrasound for tumor immunotherapy

Spatiotemporal control of the bacteria to express interferon-γ by focused ultrasound for tumor immunotherapy

Ultrasound Improved Immune Adjuvant Delivery to Induce DC Maturation and T Cell Activation.

Probiotic Engineering and Targeted Sonoimmuno-Therapy Augmented by STING Agonist.

Enhancing photothermal therapy of tumors with image-guided thermal control of gene-expressing bacteria

Ultrasound-controllable engineered bacteria for cancer immunotherapy

Genetically engineered probiotics for an optical imaging-guided tumor photothermal therapy/immunotherapy

Feasibility Between Bifidobacteria Targeting and Changes in the Acoustic Environment of Tumor Tissue for Synergistic HIFU

Nanoparticles Conjugated with Bacteria Targeting Tumors for Precision Imaging and Therapy.

Programmable Bacteria‐Based Biohybrids As Living Biotherapeutics for Enhanced Cancer Sonodynamic‐Immunotherapy

Engineering of Bacteria for the Visualization of Targeted Delivery of A Cytolytic Anticancer Agent

Dual drugs decorated bacteria irradiate deep hypoxic tumor and arouse strong immune responses

Engineered Microbial Nanohybrids for Tumor-Mediated NIR II Photothermal Enhanced Ferroptosis/Cuproptosis and Immunotherapy

Enhanced Immunogenic Cell Death and Antigen Presentation Via Engineered Bifidobacterium Bifidum to Boost Chemo-immunotherapy

US/PA/MR multimodal imaging-guided multifunctional genetically engineered bio-targeted synergistic agent for tumor therapy

Engineered Bacteria in Tumor Immunotherapy

Excessive autophagy-inducing and highly penetrable biomineralized bacteria for multimodal imaging-guided and mild hyperthermia-enhanced immunogenic cell death

Sonogenetics-controlled Synthetic Designer Cells for Cancer Therapy in Tumor Mouse Models

Modular-designed engineered bacteria for precision tumor immunotherapy via spatiotemporal manipulation by magnetic field

Nanobody‐Engineered Biohybrid Bacteria Targeting Gastrointestinal Cancers Induce Robust STING‐Mediated Anti‐Tumor Immunity